Tag: hemolytic
Press release: European Commission approves Enjaymo® (sutimlimab) for the treatment of hemolytic anemia in adults with cold agglutinin disease – 11/17/2022 at 6:50 p.m.
The European Commission approves Enjaymo ® (sutimlimab) for treatment of hemolytic anemia in adults suffering from cold agglutinin disease Enjaymo is the first and only approved treatment option for the…